VIE/ELV (VIE/ELV)

Vienna Stock Exchange: VIE/ELV · EUR

€377

-1.40 (-0.4%)· Recorded snapshot

Market cap	80.3B
Revenue (ttm)	177.7B
Net income (ttm)	4.5B
EPS (ttm)	€21.0
P/E (trailing)	17.9x
P/E (forward)	14.3x
Dividend	€5.99 (1.59%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 177.7B
Net income (ttm): 4.5B
EPS (ttm): €21.0
P/E (trailing): 17.9x
P/E (forward): 14.3x
Market cap: 80.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E14.3

P25 n/aP50 n/aP75 n/a

Trailing P/E17.9

P25 n/aP50 n/aP75 n/a

ROE11.5

P25 n/aP50 n/aP75 n/a

ROIC8.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/ELV indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-21
Employees	97,100
Employees change	-7,100
Employees growth	-6.81%
Enterprise value	EUR 98.7B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
Industry	Healthcare Plans
Is primary listing	No
ISIN number	US0367521038
Last earnings date	2026-10-21
Last refreshed	2026-10-29
Market cap	EUR 80.3B
Next earnings date	2027-01-27
Price	EUR 376.80
Price currency	EUR
Sector	Healthcare
SIC code	6324
Stock price date	2026-10-28
Symbol	vie/ELV
Website	https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.54x
Average P/E ratio (3Y)	16.27x
Average P/E ratio (5Y)	17.1x
Earnings yield	5.58%
EV/Earnings	21.82x
EV/EBIT	13.71x
EV/EBITDA	12.42x
EV/FCF	17.21x
EV/Sales	0.55x
FCF / EV yield	5.81%
FCF yield	7.14%
Forward P/E	14.33x
Graham number	297.26547
Graham upside	-21.11%
Lynch fair value	EUR 106.13
Lynch upside	-71.83%
P/(FCF - SBC) ratio	14.54x
P/(OCF - SBC) ratio	12.4x
P/B ratio	2.04x
P/E ratio	17.92x
P/FCF ratio	14x
P/OCF ratio	12.01x
P/S ratio	0.45x
Price / tangible book value	16.7x
Price/EBITDA ratio	10.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.98%
EBITDA margin	4.32%
Effective tax rate	18.35%
FCF margin	3.17%
Gross margin	26.43%
Operating margin	3.98%
Pretax margin	3.1%
Profit margin	2.55%
Profit per employee	EUR 46,840
Profitable quarters	105
Profitable years	28
Revenue per employee	EUR 1.8M
ROA	4%
ROA (5Y)	5.41%
ROCE	9.89%
ROE	11.48%
ROE (5Y)	15.57%
ROIC	8.65%
ROIC (5Y)	11.02%
SBC / revenue	0.12%
Tax / revenue	0.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-3.9%
EPS growth (Q)	17.86%
EPS growth (QoQ)	-6.56%
EPS growth 10Y	10.65%
EPS growth 3Y	-2.28%
EPS growth 5Y	1.06%
EPS growth quarters	1
EPS growth years	0
FCF growth	72.92%
FCF growth (Q)	29.03%
FCF growth (QoQ)	-38.5%
FCF growth 3Y	-7.56%
FCF growth 5Y	-7.23%
Net income growth	-7.12%
Net income growth (Q)	14.8%
Net income growth (QoQ)	-6.7%
Net income growth 3Y	-5.01%
Net income growth 5Y	-1.41%
Net income growth quarters	1
Net income growth years	0
OCF growth	54.64%
OCF growth (Q)	11.63%
OCF growth (QoQ)	-33.77%
OCF growth 10Y	6.78%
OCF growth 3Y	-7.23%
OCF growth 5Y	-6.28%
Revenue growth	3.6%
Revenue growth (Q)	1.42%
Revenue growth (QoQ)	1.89%
Revenue growth 10Y	9.24%
Revenue growth 3Y	6.17%
Revenue growth 5Y	8.56%
Revenue growth quarters	56
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -952.8M
EBIT	EUR 7.1B
EBITDA	EUR 7.7B
EPS	EUR 21.02
Financing cash flow	EUR -2.6B
Free cash flow	EUR 5.7B
Free cash flow minus SBC	EUR 5.5B
Gross profit	EUR 47B
Income taxes	EUR 1B
Investing cash flow	EUR -2.6B
Net borrowing	EUR 527.4M
Net cash flow	EUR 1.4B
Net income	EUR 4.5B
Operating cash flow minus SBC	EUR 6.5B
Operating income	EUR 7.1B
Revenue	EUR 177.7B
Stock-based compensation	EUR 211.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 182.06
Debt / EBITDA	3.47
Debt / equity	0.69
Debt / FCF	4.72
Goodwill	EUR 25.4B
Interest coverage	5.55
Net cash (debt)	EUR -18B
Net cash / market cap	-22.37%
Net debt / EBITDA	2.34
Net debt / equity	0.46
Net debt / FCF	3.13
Piotroski F-Score	5
Property, plant and equipment	EUR 4.1B
Shareholders' equity	EUR 39.4B
Tangible book value	EUR 4.8B
Tangible book value per share	EUR 22.25
Total assets	EUR 112.5B
Total cash	EUR 33.3B
Total debt	EUR 27.1B
Total liabilities	EUR 73.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current ratio	1.47
Net working capital	EUR 10.5B
Quick ratio	1.34
Working capital	EUR 19.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.33%
Dividend growth	-0.17%
Dividend growth (3Y)	2.67%
Dividend growth (5Y)	9.32%
Dividend growth years	0
Dividend payment date	2026-12-18
Dividend payment years	8
Dividend payout frequency	Quarterly
Dividend per share	EUR 5.99
Dividend yield	1.59%
Ex-dividend date	2026-12-04
Last dividend	EUR 1.54
Payout ratio	29.17%
Shareholder yield	4.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 336.03
1D price change	-0.37%
1M price change	6.14%
1M total return	6.14%
1W price change	-3.36%
1W total return	-3.36%
1Y price change	28.65%
1Y return CAGR	31.22%
1Y total return	31.19%
20-day SMA	EUR 372.00
200-day SMA	EUR 322.32
3M price change	13.84%
3M total return	14.33%
3Y price change	-10.29%
3Y return CAGR	-1.93%
3Y total return	-5.67%
50-day SMA	EUR 358.92
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 400.60
52-week high date	2026-10-22
52-week low	EUR 240.80
52-week low date	2026-03-10
5Y price change	0.35%
5Y return CAGR	1.54%
5Y total return	7.95%
6M price change	24.64%
6M total return	25.7%
All-time high	EUR 552.90
All-time high date	2022-11-01
All-time low	EUR 168.52
All-time low date	2020-03-23
Average true range (ATR)	EUR 7.07
Average volume	0
Change from 52-week high	-5.94%
Change from 52-week low	56.48%
Change from all-time high	-31.85%
Change from all-time low	123.59%
Change from open	-0.19%
Day's gap	-0.19%
High price	EUR 378.40
Low price	EUR 376.80
Monthly RSI	56.74
Open price	EUR 377.50
Position in 52-week range	0%
Previous close	EUR 378.20
Price vs 150-day SMA	12.13%
Price vs 20-day SMA	1.29%
Price vs 200-day SMA	16.9%
Price vs 50-day SMA	4.98%
Relative volume	1.45
RSI	53.85
Sharpe ratio	0.86
Sharpe ratio (3Y)	-0.12
Sharpe ratio (5Y)	0.13
Sortino ratio	1.38
Sortino ratio (3Y)	0.03
Sortino ratio (5Y)	0.37
Weekly RSI	60.07
YTD price change	28.16%
YTD total return	30.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	215.6M
Shares change (QoQ)	-0.14%
Shares change (YoY)	-3.33%
Shares held by insiders	0.11%
Shares held by institutions	95.65%
Short ratio	4.5 days

Deeper analysis on VIE/ELV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/ELV report

Is a complete VIE/ELV research report available?

No complete published report is available for vie/ELV (VIE/ELV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/ELV (VIE/ELV)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/ELV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/ELV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/ELV

Frequently asked questions